Privia Health Group, INC 8-K filings

Privia Health Group, Inc. announced robust financial results for the second quarter of 2026, exceeding prior year performance and leading to an upward revision of full-year guidance.

Privia Health Group, Inc. announced the immediate resignation of director Shawn Morris from its Board and Compliance Committee, effective July 6, 2026.

Privia Health Group stockholders approved the election of three directors, executive compensation, and the appointment of auditors at the 2026 Annual Meeting.

Privia Health Group, Inc. announced robust first quarter 2026 financial results, exceeding expectations with significant growth in revenue and key operating metrics, while reiterating full-year guidance.

Privia Health Group, Inc. reported full-year 2025 financial results exceeding all guidance ranges and provided an optimistic outlook for 2026 with projected Adjusted EBITDA growth.

Privia Health Group, Inc. announced the successful closing of its acquisition of an Accountable Care Organization business from Evolent Health, Inc.

Privia Health Group, Inc. reported very strong third quarter and year-to-date 2025 financial results, with significant growth in net income and adjusted EBITDA, leading to an upward revision of its full-year guidance.

Privia Health Group, Inc. announced the passing of Patricia Maryland, a Board Director and Chair of its Compliance Committee, after five years of service.

Privia Health Group, Inc. announced a definitive agreement to acquire an Accountable Care Organization business from Evolent Health for $100 million cash and up to $13 million contingent payment.

Privia Health Group, Inc. announced its ACOs generated over $233 million in shared savings for 2024, leading to an increased 2025 Adjusted EBITDA guidance.

Privia Health Group, Inc. announced robust second quarter 2025 financial results, including significant growth in key operating metrics and an upward revision of its full-year 2025 guidance.

Privia Health Group, Inc. announced the expansion of its Board of Directors to ten members and the appointment of Lance V. Berberian, a seasoned technology and cybersecurity expert, as a Class III director and member of the Audit Committee, effective July 15, 2025.

Privia Health Group's stockholders elected directors and approved executive compensation at the 2025 Annual Meeting.

Privia Health announced strong first-quarter 2025 financial results, highlighted by revenue growth, increased profitability, and an expansion into Arizona, leading to an increased full-year outlook.

Privia Health Group amends Parth Mehrotra's employment agreement, increasing his base salary, bonus potential, and long-term incentive award.

Privia Health announced its fourth quarter and full-year 2024 financial results, exceeding guidance across all operating and financial metrics and projecting continued momentum into 2025 despite industry headwinds.

Privia Health reaffirmed its 2024 financial guidance and showcased its growth strategy and performance at the J.P. Morgan Healthcare Conference in January 2025.

Privia Health announced strong third-quarter results, exceeding expectations and raising its full-year 2024 guidance across all key metrics.

Privia Health reported strong second-quarter 2024 results, exceeding expectations and leading to an increase in full-year 2024 guidance across all key metrics.

Bill Sullivan has resigned from Privia Health Group's Board of Directors and Audit Committee, effective July 1, 2024.

Privia Health presented its unique physician alignment model, strong growth metrics, and consistent financial performance at the William Blair 44th Annual Growth Stock Conference.

Privia Health Group has amended its previous 8-K filing to correct the voting results for Proposal No. 2 regarding executive compensation at its 2024 annual meeting.

Privia Health Group's stockholders approved amendments to the company's charter and bylaws, removing supermajority voting provisions and limiting officer liability, and elected four Class II directors at the 2024 Annual Meeting.

Privia Health's first quarter 2024 results show a revenue increase of 7.5% year-over-year, but a significant decrease in net income, while the company reaffirmed its full-year 2024 guidance.

Privia Health reported strong financial results for 2023, meeting all guidance metrics and setting expectations for 2024 with a focus on growth and strategic adjustments in the Medicare Advantage market.

Privia Health has appointed Edward C. Fargis as its new Executive Vice President & General Counsel, succeeding Thomas Bartrum who will depart after a transition period.